|
Method
|
Number of Significant genes
|
Overlap with CGC
|
Method consensus
|
CGC Rank
|
Consensus Rank
|
Average Rank
|
|---|
|
Breast cancer
|
|
CADD
|
263
|
0.041
|
0.45
|
1
|
4
|
2.5
|
|
DANN
|
158
|
0.011
|
0.57
|
6
|
2
|
4
|
|
Fathmm-MKL coding
|
178
|
0.022
|
0.58
|
2
|
2
|
2
|
|
Fathmm-MKL noncoding
|
184
|
0.021
|
0.49
|
3
|
3
|
3
|
|
MetaLR
|
174
|
0.013
|
0.5
|
5
|
3
|
4
|
|
SPIDEX
|
178
|
0.015
|
0.12
|
4
|
5
|
4.5
|
|
VEST3
|
171
|
0.021
|
0.62
|
3
|
1
|
2
|
|
Lung cancer
|
|
CADD
|
121
|
0.017
|
0.48
|
2
|
4
|
3
|
|
DANN
|
142
|
0.013
|
0.25
|
3
|
6
|
4.5
|
|
Fathmm-MKL coding
|
138
|
0.021
|
0.66
|
1
|
1
|
1
|
|
Fathmm-MKL noncoding
|
149
|
0.011
|
0.54
|
4
|
3
|
3.5
|
|
MetaLR
|
178
|
0.007
|
0.46
|
5
|
5
|
5
|
|
SPIDEX
|
171
|
0.002
|
0.11
|
6
|
7
|
6.5
|
|
VEST3
|
164
|
0.011
|
0.57
|
4
|
2
|
3
|
